Kliniek ViaSana
Mill, Netherlands
NCT Number: NCT03961152
Less is known about pain and opiate use at home directly after total knee replacement (TKR). Regarding side effects, low opiate use is desired. An e-health application, PainCoach app, was developed to guide patients in pain control and opiate use.
The aim of this study was to investigate the effect of the PainCoach app on pain and opiate use in TKR patients in the first two weeks at home after surgery. The hypothesis was that the use of this app would decrease pain and opiate use.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Mill, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In response to the patient's input of the pain experienced (no pain, bearable pain, unbearable pain, or untenable pain), the app gave advice on pain medication use, exercises/rest and when to call the clinic from day 1 until day 14 after surgery.
Time frame: 14 measurement points: daily from day 1 to 14 after surgery
Pain at rest was daily measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
Time frame: 14 measurement points: daily from day 1 to 14 after surgery
Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
Time frame: 14 measurement points: daily from day 1 to 14 after surgery
Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
Time frame: 14 measurement points: daily from day 1 to 14 after surgery
Oxycodon (5 mg per tablet) use was recorded in quantities per 24 hours
Time frame: 1 month after surgery
Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
Time frame: 1 month after surgery
Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
Time frame: 1 month after surgery
Measured with VAS from 0 (no pain) to 100 (worst imaginable pain)
Time frame: 14 measurement points: daily from day 1 to 14 after surgery
i.e. NSAID (Diclofenac), acetaminophen and/or Gabapentin were recorded in quantities per 24 hours
Time frame: 14 measurement points: daily from day 1 to 14, and at 1 month after surgery
Measured with a happy smiley (acceptable pain) and a sad smiley (unacceptable pain)
Time frame: 14 measurement points: daily from day 1 to 14 after surgery
Measured on a 3-item scale; did too much, exactly enough, or could have done more exercises
Time frame: 1 month after surgery
Measured with the Knee injury and Osteoarthritis Outcome Score - Physical Function Short-form (KOOS-PS) with a total score from 0 (no difficulty) to 100 (extreme difficulty)
Time frame: 1 month after surgery
Measured with the Oxford Knee Score (OKS) with a total score from 0 (most severe symptoms) to 48 (least severe symptoms)
Time frame: 1 month after surgery
Measured with the EuroQol-5D 3 level version (EQ-5D-3L) consisting of two scores: EQ Visual Analogue Scale (EQ VAS) score from 0 (worst imaginable health state) to 100 (best imaginable health state), and EQ-5D descriptive system (EQ-5D index).
Time frame: Day 14 after surgery
Usability, added value, and likelihood of being recommended to others was recorded on a 5-item scale ranging from totally agree to totally disagree
Time frame: From day 1 to 14 after surgery
Measured with recording the actual amount of app use and defining active use as at least 12 times in total
Kliniek ViaSana
Other
Effect of the PainCoach App on Pain and Opiate Use in the First Two Weeks After Total Knee Replacement: Randomised Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06521619
Agnosia, Motor Function
New Taipei City, Taiwan
View Trial DetailsNCT04166539
Metallosis, Neurologic Manifestations
Rochester, Minnesota, United States
View Trial DetailsNCT03286543
Musculoskeletal Diseases, Neurologic Manifestations
La Jolla, California, United States
View Trial DetailsNCT02468934
Musculoskeletal Diseases, Neurologic Manifestations
La Jolla, California, United States
View Trial Details